ARCHIVES

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Kripke, Fidler To Leave FCRF for M.D. Anderson; George Todaro Takes Job With New Seattle Firm

March 4, 1983

NIH Modifies IRG voting Procedure In Success Rate Switch

August 30, 1991

FDA Advisors Okay DDC For AIDS Treatment In Comb With AZT

May 8, 1992

Perifosine Increases PFS In Phase II Study

December 30, 2011

Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions

November 4, 1983

Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete.

June 25, 2004